Down-regulation of PDCD4 expression is an independent predictor of poor prognosis in human renal cell carcinoma patients

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 3, 2012, Pages 529-535

  Li, Xiancheng ^a   Xin, Shiyong ^a   Yang, Deyong ^a   Li, Xiunan ^a   He, Zhongzhou ^a   Che, Xiangyu ^a   Wang, Jianbo ^a   Chen, Feng ^a   Wang, Xuejiang ^a   Song, Xishuang ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

PDCD4; Prognosis; Renal cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROGRAMMED CELL DEATH 4 GENE; SURVIVAL TIME; TISSUE SECTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; CHEMISTRY; KAPLAN MEIER METHOD; KIDNEY TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL;

APOPTOSIS REGULATORY PROTEIN; PDCD4 PROTEIN, HUMAN; RNA BINDING PROTEIN; TUMOR MARKER;

ADULT; AGED; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RNA-BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84859706600     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1121-y     Document Type: Article

References (30)

1. Allgayer H (2010) Pdcd4, a colon cancer prognostic that is regulated by a microRNA. Crit Rev Oncol Hematol 73:185-191
2. Böhm M, Sawicka K, Siebrasse JP, Brehmer-Fastnacht A, Peters R, Klempnauer KH (2003) The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA. Oncogene 22:4905-4910 (Pubitemid 36981280)
3. Campbell SC, Novick AC, Bukowski RM (2007) Renal tumors. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds) Campbell-Walsh urology, 9th edn. Saunders, Philadelphia, pp 1567-1637
4. Chen Y, Knosel T, Kristiansen G et al (2003) Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol 200:640-646 (Pubitemid 36987314)
5. Cmarik JL, Min H, Hegamyer G et al (1999) Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc Natl Acad Sci USA 96:14037-14042
6. Cohen HT, McGovern FJ (2005) Renal-cell carcinoma. N Engl J Med 353:2477-2490 (Pubitemid 41770167)
7. Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, Pagano M (2006) S6K1- and beta TRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314:467-471 (Pubitemid 44628968)
8. Gao F, Zhang P, Zhou C et al (2007) Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma. Oncol Rep 17:123-128
9. Gao F, Wang X, Zhu F et al (2009) PDCD4 gene silencing in gliomasis associated with 50CpG island methylation and unfavorable prognosis. J Cell Mol Med 13:4257-4267
10. Göke R, Barth P, Schmidt A, Samans B, Lankat-Buttgereit B (2004) Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). Am J Physiol Cell Physiol 287:C1541-C1546 (Pubitemid 39507671)
11. Jansen AP, Camalier CE, Colburn NH (2005) Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res 65:6034-6041 (Pubitemid 40994387)
12. Lankat-Buttgereit B, Göke R (2009) The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol Cell 101:309-317
13. Lankat-Buttgereit B, Gregel C, Knolle A, Hasilik A, Arnold R, G̈ oke R (2004) Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase typeII. Mol Cell Endocrinol 214:149-153 (Pubitemid 38210124)
14. Lankat-Buttgereit B, Lenschen B, Schmidt H, Goke R (2008) The action of Pdcd4 may be cell type specific: evidence that reduction of dUTPase levels might contribute to its tumor suppressor activity in Bon-1 cells. Apoptosis 13:157-164
15. Leupold JH, Yang HS, Colburn NH, Asangani I, Post S, Allgayer H (2007) Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene 26:4550-4562 (Pubitemid 47039134)
16. Ma G, Guo KJ, Zhang H et al (2005) Expression of programmed cell death 4 and its clinicopathological significance in human pancreatic cancer. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 27:597-600
17. Matsuhashi S, Narisawa Y, Ozaki I, Mizuta T (2007) Expression patterns of programmed cell death 4 protein in norma human skin and some representative skin lesions. Exp Dermatol 16:179-184 (Pubitemid 46242959)
18. Mudduluru G, Medved F, Grobholz R et al (2007) Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an indeoendent prognostic factor in resected colorectal cancer. Cancer 110:1679-1707
19. Murphy WM, Grignon DJ, Perlman EJ (2004) Kidney tumors in adults. In: Murphy WM, Grignon DJ, Perlman EJ (eds) Tumor of the kidney, bladder, and related urinary structures. American registry of pathology, Washington, pp 101-240
20. Onishi Y, Hashimoto S, Kizaki H (1998) Cloning of the TIS gene suppressed by topoisomerase inhibitors. Gene 215:453-459 (Pubitemid 28382949)
21. Ozpolat B, Akar U, Steiner M et al (2007) Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells. Mol Cancer Res 5:95-108
22. Palamarchuk A, Efanov A, Maximov V, Aqeilan RI, Croce CM, Pekarsky Y (2005) Akt phosphorylates and regulates pdcd4 tumor suppressor protein. Cancer Res 65:11282-11286 (Pubitemid 41821683)
23. Schlichter U, Burk O, Worpenberg S, Klempnauer KH (2001) The chicken Pdcd4 gene is regulated by v-Myb. Oncogene 20:231-239 (Pubitemid 32150268)
24. Shibahara K, Asano M, Ishida Y, Aoki T, Koike T, Honjo T (1995) Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene 166:297-301 (Pubitemid 26007637)
25. Van Spronsen DJ, Mulders PF, De Mulder PH (2005) Novel treatments for metastatic renal cell carcinoma. Crit Rev Oncol Hematol 55:177-191 (Pubitemid 41219690)
26. Wang X, Wei Z, Gao F et al (2008) Expression and prognostic significance of PDCD4 in human epithelial ovarian carcinoma. Anticancer Res 28:2991-2996
27. Wen YH, Shi X, Chiriboga L, Matsahashi S, Yee H, Afonja O (2007) Alterations in the expression of PDCD4 in ductal carcinoma of the breast. Oncol Rep 18:1387-1393
28. Yoshinaga H, Matsuhashi S, Fujiyama C, Masaki Z (1999) Novel human PDCD4 (H731) gene expression in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody. Pathol Int 49:1067-1077 (Pubitemid 30193505)
29. Zhang Z, Du Bois RN (2001) Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor. Oncogene 20:4450-4456 (Pubitemid 32772427)
30. Zhang H, Ozaki I, Mizuta T et al (2006) Involvement of programmed cell death 4 in transforming growth factor-b1-induced apoptosis in human hepatocellular carcinoma. Oncogene 25:6101-6112 (Pubitemid 44562408)